These findings imply that pathogenic factors, including brain injury and hyperglycemia, would stimulate SGLT2 expression, further leading to a cascade of detrimental effects such as enhanced glucose reabsorption, neuronal damage, and atherogenesis (Fig. 1). The gene discussed is SLC5A2; the disease is Hyperglycemia.